
Sign up to save your podcasts
Or


FDA approved the controversial Alzheimer’s drug aducanumab. We'll talk with Penn Memory Center's Dr. Jason Karlawish about the decision and the state of Alzheimer's research.
By WHYY4.6
249249 ratings
FDA approved the controversial Alzheimer’s drug aducanumab. We'll talk with Penn Memory Center's Dr. Jason Karlawish about the decision and the state of Alzheimer's research.

62 Listeners